KIORA PHARMACEUTICALS, INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a5d11112-42d6-418a-b2ef-5469ccd5818c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-10.8k | 2025-01-01 – 2025-12-31 | evidence 0001372514-26-000040 |
| FY 2024 | $3.6k | 2024-01-01 – 2024-12-31 | evidence 0001372514-26-000040 |
| FY 2023 | $-12.5k | 2023-01-01 – 2023-12-31 | evidence 0001372514-26-000040 |
| FY 2022 | $-13.6M | 2022-01-01 – 2022-12-31 | evidence 0001372514-23-000050 |
| FY 2021 | $-13.8M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-001931 |
| FY 2020 | $-6.9M | 2020-01-01 – 2020-12-31 | evidence 0001410578-22-001931 |
| FY 2019 | $-7.1M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-029162 |
| FY 2018 | $-10.8M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-011634 |
| FY 2017 | $-13.2M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-011634 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
KIORA PHARMACEUTICALS, INC. — all facts · Revenue · Operating Income